Wenbo Sai, PhD Center for Drug Evaluation

Dr. Wenbo Sai, holds a doctorate in Microbiology and Biochemical Pharmacy of China Pharmaceutical University and has been a reviewer in Pharmacy Department of Biological Products of Center for Drug Evaluation since 2017. He has mainly engaged in pharmaceutical professional technical evaluation of products of recombinant biotechnology and advanced treatment, and drafted normative technical documents such as Guidelines for Platform Process Validation of Viral Removal and Inactivation of Recombinant Biotechnology Products. He is now involved in the revision of issues of ICH Q5A (R2) as an expert.